In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

Innovative, nontoxic molecules developed by a research team at the Institut national de la recherche scientifique (INRS) ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Humanity, according to Michael Zey, a noted sociologist, has the wherewithal to controlling its own destiny, owing to ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah biochemist whose discoveries helped make the drug happen worries government cuts ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

While people living with HIV can lead virtually normal lives thanks to antiretroviral therapy (ART), HIV persists in a latent ...

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...